ArticleEuroasian journal of hepato-gastroenterology
Comparison of Immediate Oral Feeding vs Conventional Oral Feeding in Patients with Mild to Moderately Severe Acute Pancreatitis: A Randomized Controlled Trial from a Tertiary Care Center in North India.
Article in Euroasian journal of hepato-gastroenterology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Aim and background: Acute pancreatitis (AP) is an inflammatory condition of the pancreas with varying severity, traditionally managed by delaying oral feeding to prevent enzyme stimulation. However, prolonged fasting may worsen patient outcomes by increasing catabolism and the risk of bacterial translocation. This study aims to compare the effects of immediate oral feeding (IOF) within 24 hours of hospital admission vs conventional oral feeding (COF) after 48 to 72 hours in patients with mild to moderately AP, hypothesizing that IOF will reduce length of hospital stay (LOHS) without increasing complications. Methods: An open labeled, stratified, randomized controlled trial (RCT) involving adult patients with mild to moderate AP, conducted at Government Medical College and Hospital, Chandigarh, India, with 100 adult participants, over a duration of 18 months and registered in the Clinical Trial Registry of India (CTRI/2023/02/049370) on February 1, 2023. Patients were randomized into two treatment groups: IOF (intervention group) and COF (control group). In the IOF group, the diet was started within 24 hours of admission, and in the COF, the diet was started in a stepwise manner after 48-72 hours. Decisions regarding the progression of the diet and the timing of hospital discharge were made by the medical team independently, without involvement from the study team members. The primary outcome was to observe the LOHS, while the secondary outcome was to observe recurrence of abdominal pain and diet intolerance and to analyze the laboratory parameters between the two groups. Results: We randomized 100 patients: 51 to the IOF and 49 to the COF groups. The LOHS was significantly shorter in the IOF group, with a mean of 4.5 ± 6.9 days, compared to 7.5 ± 5.5 days in the COF group ( Conclusion: Administration of an immediate oral low-fat solid diet to patients with mild to moderately severe AP appears safe, feasible, and may reduce the LOHS, with comparable results to COF regarding diet intolerance, recurrence of pain, and complications. Further research is needed to compare low- and normal-fat diets for optimal outcomes. Clinical significance: This study shows that IOF in mild to moderately severe AP can safely reduce hospital stays without increasing complications. It highlights the potential of early nutritional intervention to enhance recovery and streamline care. How to cite this article: Sandeep VS, Dahra A, Singh P,
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.